December 21, 2023
2 mins read

WHO Declares JN.1 as Standalone Covid Variant

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention…reports Asian Lite News

The World Health Organization (WHO) has declared the new Covid-19 variant — JN.1 — as a “standalone variant of interest”.

WHO’s decision was prompted by the variant’s ability to spread fast among the community. It said the decision was due to the strain’s ‘rapidly increasing spread’.

The WHO on Tuesday announced that it is classifying a new Covid-19 strain – JN.1 – as a standalone variant of interest “due to its rapidly increasing spread”, media reports said adding that the new variants’ characteristics and a growth advantage over other strains in circulation prompted the early warning, reports said.

Though WHO assessed the global public health risk of JN.1 as low, it warned that countries approaching winter should be aware that Covid-19 and other pathogens may exacerbate respiratory disease seasons.

“Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries,” it said.

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention.

The agency expects that JN.1’s prevalence in the US will continue to increase in the winter months.

WHO considers BA.2.86 sub lineages to be variants of interest, but now JN.1 is listed as a variant of interest separate from its parent lineage, also known as pirola.

WHO defines a variant of interest as a strain with genetic mutations, according to US News & World Report.

Covid-19 tests and treatments are expected to work on JN.1. So far, it doesn’t appear to cause more severe disease but it does seem to have advantages over the other strains.

“While there is a rapid increase in JN.1 infections, and likely increase in cases, available limited evidence does not suggest that the associated disease severity is higher as compared to other circulating variants,” WHO said in its risk assessment of the strain.

Coronavirus vaccines are also expected to work on JN.1. “Current vaccines, including those based on ancestral strain as well as the updated monovalent XBB vaccines continue to provide protection against severe disease and death, including against JN.1,” WHO’s Maria Van Kerkhove said on social media.

ALSO READ-India Topped SE Asia in Malaria Cases and Deaths: WHO

Previous Story

Controversial Colorado Ruling Spurs GOP Action

Next Story

India Emphasizes Counter terrorism Efforts in Afghanistan

Latest from -Top News

Modi Eyes Trade Deals in Maldives

PM Modi will arrive in Maldives on July 25 which would be the second and final leg of his two-nation visit, following the visit to the United Kingdom, starting Wednesday….reports Asian Lite

Russia Strikes Back at EU

The Council of the European Union approved the 17th and 18th packages of sanctions on Russia on May 20 and July 18…reports Asian Lite News Russia has significantly expanded its entry ban

PM Modi Due in UK

PM Modi’s visit to the UK, scheduled for July 23–24, comes at the invitation of British counterpart Keir Starmer and will be his fourth trip to the country….reports Asian Lite News Prime

Victory First, Then Peace?

Katz stressed the importance of meeting the war’s goals as set, primarily the return of all Israeli hostages and the surrender of Hamas….reports Asian Lite News Israeli Defence Minister Israel Katz said

US Brings Up Old Claim, India Pushes Back

US Raises Trump’s India-Pakistan Claim at UN; India Reaffirms Bilateral Stand…reports Asian Lite News The US brought President Trump’s May claim of resolving the India-Pakistan conflict to the Security Council, but New
Go toTop

Don't Miss

Scotland to lift all curbs by Aug 9

Earlier, Prime Minister Boris Johnson has warned of a “rough

UK govt to stop publishing coronavirus data

The country’s remaining COVID restrictions, including the legal requirement to